Lonza reports profit jump in 2007

Basel-based chemical and biotechnology company Lonza has reported 51 per cent growth in net income to SFr301 million ($274.7 million) in 2007.

This content was published on January 23, 2008 - 08:37

Earnings before interest and tax grew by 36 per cent to SFr408 million, exceeding analysts' expectations, and Lonza reported a strong improvement in cash flow.

This performance represents a significant strengthening of Lonza's ability to generate further sustainable growth, a company statement said.

The company said its revised growth strategies for the Bioscience, Nutrition Ingredients and Microbial Control units were designed to deliver enhanced returns.

"Lonza continues to successfully achieve critical milestones in its long-term strategic plan," it said.

The board of directors is proposing a dividend of SFr1.75 per share.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.